Chargement en cours...
Comparison of two immunoassays for the measurement of serum HE4 for ovarian cancer
INTRODUCTION: The use of Human Epididymis Protein 4 (HE4) as a biomarker for ovarian cancer is gaining traction, providing the impetus for development of a high throughput automated HE4 assay that is comparable to the conventional manual enzyme immunometric-assay (EIA). The aim of this study was to...
Enregistré dans:
| Publié dans: | Pract Lab Med |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Elsevier
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8138765/ https://ncbi.nlm.nih.gov/pubmed/34036134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.plabm.2021.e00235 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|